About Me
Dr. Gary Doolittle is the Capitol Federal Masonic Professor of Medicine in the Division of Medical Oncology at the University of Kansas Medical Center and the Medical Director of the Masonic Cancer Alliance (MCA), the outreach network of the KU Cancer Center.
Dr. Doolittle has been a faculty member in the Division of Medical Oncology at the University of Kansas Medical Center for over 35 years, specializing in the treatment of malignant melanoma. Since 2007, as Medical Director of the MCA, he has led the effort to advance the quality and reach of cancer prevention, early detection, cancer treatment and survivorship throughout the region.
Dr. Doolittle has written many publications on a variety of oncology topics, with a major emphasis on using technology to enhance the care of rural cancer patients. He currently serves as the Principal Investigator for the KU Cancer Center/MCA National Cancer Institute Community Oncology Research Program (NCORP), a grant designed to extend cancer clinical trials to the rural sector in the state of Kansas and western Missouri. Most recently, Dr. Doolittle and his Clinical Team established an FDA-approved therapy at KUCC called TIL (Tumor Infiltrating Lymphocyte), a personalized cellular immunotherapy that uses a patient’s own immune cells to fight advanced cancer. The KU Cancer Center is the only FDA Authorized Treatment Center for TIL in the region.
Dr Doolittle earned his medical degree from the University of Kansas Medical Center, where he also completed a residency in internal medicine and a fellowship in hematology/oncology.